DK1151746T3 - Mikro-kapsler til vedvarende frigivelse af lægemidler - Google Patents

Mikro-kapsler til vedvarende frigivelse af lægemidler

Info

Publication number
DK1151746T3
DK1151746T3 DK00985267T DK00985267T DK1151746T3 DK 1151746 T3 DK1151746 T3 DK 1151746T3 DK 00985267 T DK00985267 T DK 00985267T DK 00985267 T DK00985267 T DK 00985267T DK 1151746 T3 DK1151746 T3 DK 1151746T3
Authority
DK
Denmark
Prior art keywords
drugs
microcapsules
sustained release
plasticiser
interested
Prior art date
Application number
DK00985267T
Other languages
English (en)
Inventor
Duena Antonio Parente
Garces Josep Garces
Munoz Angel Bonilla
Colome David Cumillera
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipotec Sa filed Critical Lipotec Sa
Application granted granted Critical
Publication of DK1151746T3 publication Critical patent/DK1151746T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
    • A61P5/22—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of calcitonin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK00985267T 1999-12-17 2000-12-15 Mikro-kapsler til vedvarende frigivelse af lægemidler DK1151746T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES009902768A ES2169980B1 (es) 1999-12-17 1999-12-17 Microcapsulas para la liberacion prolongada de farmacos.
PCT/ES2000/000475 WO2001043724A1 (es) 1999-12-17 2000-12-15 Microcapsulas para la liberacion prolongada de farmacos

Publications (1)

Publication Number Publication Date
DK1151746T3 true DK1151746T3 (da) 2003-07-21

Family

ID=8310957

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00985267T DK1151746T3 (da) 1999-12-17 2000-12-15 Mikro-kapsler til vedvarende frigivelse af lægemidler

Country Status (13)

Country Link
US (3) US20020187196A1 (da)
EP (1) EP1151746B1 (da)
JP (1) JP5021880B2 (da)
AT (1) ATE234608T1 (da)
AU (1) AU774680B2 (da)
BR (1) BRPI0008197B8 (da)
CA (1) CA2362769C (da)
DE (1) DE60001717T2 (da)
DK (1) DK1151746T3 (da)
ES (2) ES2169980B1 (da)
MX (1) MXPA01008348A (da)
PT (1) PT1151746E (da)
WO (1) WO2001043724A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040097419A1 (en) * 2002-11-19 2004-05-20 Holger Petersen Organic compounds
WO2006123360A2 (en) * 2005-03-01 2006-11-23 Sun Pharmaceutical Industries Limited Microspheres containing octreotide acetate
KR20130024987A (ko) * 2005-12-22 2013-03-08 노파르티스 아게 옥트레오티드 및 ２종 이상의 폴리락티드-코-글리콜리드 중합체를 포함하는 서방형 제제
ES2324009B1 (es) * 2007-11-23 2010-05-21 Gp Pharm S.A. Composicion farmaceutica de liberacion sostenida de somatostatina o un analogo suyo.
KR102039494B1 (ko) * 2011-12-22 2019-11-01 라이프 테크놀로지스 코포레이션 세포 배양 배지 및 방법
CN105267153B (zh) * 2015-11-27 2018-05-11 上海苏豪逸明制药有限公司 一种曲普瑞林缓释微粒及其制备方法
CN110954491B (zh) * 2019-12-09 2022-11-15 北京博恩特药业有限公司 用于测量醋酸戈舍瑞林缓释植入剂体外溶出度的方法
JP7371519B2 (ja) 2020-02-14 2023-10-31 村田機械株式会社 自動倉庫

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2151185A (en) * 1936-01-16 1939-03-21 Carbide & Carbon Chem Corp Esters of glycol monoesters and acylated hydroxy acids
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
WO1981003565A1 (en) 1980-05-29 1981-12-10 H Nicklaus Stringed musical instrument teaching device and process
GB2132887A (en) * 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
CH661206A5 (fr) 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
JPS60100516A (ja) 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
DE3678308D1 (de) * 1985-02-07 1991-05-02 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
JP2551756B2 (ja) 1985-05-07 1996-11-06 武田薬品工業株式会社 ポリオキシカルボン酸エステルおよびその製造法
CH665558A5 (en) 1985-10-09 1988-05-31 Debiopharm Sa Phase sepn. prodn. of microcapsules for water soluble pharmaceuticals - using fluoro-substd. aliphatic hydrocarbon as non-solvent in the hardening stage
GB2209937B (en) 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
CH679207A5 (da) 1989-07-28 1992-01-15 Debiopharm Sa
IT1243390B (it) 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
SE9100610D0 (sv) * 1991-03-04 1991-03-04 Procordia Ortech Ab Bioresorbable material for medical use
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.
US5518730A (en) 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
WO1994021237A1 (en) 1993-03-15 1994-09-29 The Board Of Regents Of The University Of Michigan System for controlled release of antiarrhythmic agents
CN1191787C (zh) 1995-10-05 2005-03-09 株式会社东芝 X射线摄像装置
SE505146C2 (sv) * 1995-10-19 1997-06-30 Biogram Ab Partiklar för fördröjd frisättning
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
KR100508229B1 (ko) * 1997-03-18 2005-08-17 선스타 가부시키가이샤 고체 입자 형성용 조성물
GB9718986D0 (en) * 1997-09-09 1997-11-12 Danbiosyst Uk Controlled release microsphere delivery system
US6818018B1 (en) * 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels

Also Published As

Publication number Publication date
BRPI0008197B1 (pt) 2017-05-09
WO2001043724A1 (es) 2001-06-21
US20020187196A1 (en) 2002-12-12
US9789064B2 (en) 2017-10-17
US20080233198A1 (en) 2008-09-25
BR0008197A (pt) 2002-01-22
CA2362769C (en) 2008-09-09
DE60001717T2 (de) 2004-03-18
ES2169980B1 (es) 2003-11-01
EP1151746B1 (en) 2003-03-19
CA2362769A1 (en) 2001-06-21
ES2194793T3 (es) 2003-12-01
ATE234608T1 (de) 2003-04-15
DE60001717D1 (de) 2003-04-24
MXPA01008348A (es) 2004-03-19
ES2169980A1 (es) 2002-07-16
JP2003516960A (ja) 2003-05-20
BRPI0008197B8 (pt) 2021-05-25
JP5021880B2 (ja) 2012-09-12
US20050123618A1 (en) 2005-06-09
EP1151746A1 (en) 2001-11-07
PT1151746E (pt) 2003-07-31
AU2173501A (en) 2001-06-25
AU774680B2 (en) 2004-07-01

Similar Documents

Publication Publication Date Title
NO995753D0 (no) Gastroretarderende mikrosfaerer med styrt frigivelse for bedret administrasjon av medikament
DZ2685A1 (fr) Formulation pharmaceutique orale à libération prolongée.
NO20016107D0 (no) Mesalazin-kontrollert frigivelse orale farmasöytiske sammensetninger
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
DK1183014T3 (da) Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
ITMI20001173A0 (it) Composizioni farmaceutiche a rilascio prolungato per la somministrazione parenterale di sostanze idrofile biologicamente attiva.
HUP0101237A1 (hu) Elnyújtott kioldódású gyógyszerkészítmények
PT1439829E (pt) Medicamento contendo 3-(3-dimetilamino-1-etil-2-metilpropil)-fenol proporcionando libertacao retardada da substancia activa
BR9607752B1 (pt) formulação farmacêutica de microcápsula de liberação controlada.
HK1027563A1 (en) Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same.
DK1578406T3 (da) Farmaceutisk sammensætning med modificeret frigivelse
DK1108424T4 (da) Matrixtablet til langvarig frisætning af trimetazidin efter oral administrering.
DE59907481D1 (de) Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff
DK1151746T3 (da) Mikro-kapsler til vedvarende frigivelse af lægemidler
NO985299D0 (no) Preparat av prostaglandin I-derivat med langsom frigj°ring
NO20091467L (no) Farmasoytiske formuleringer som omfatter klopidogrel
DK1071397T3 (da) Levosimendan-holdige lægemidler til oral indgivelse med kontrolleret frisætning af det aktive middel
DZ3163A1 (fr) Nouvelle substance pharmaceutique.
ITMI20011457A0 (it) Composizione farmaceutica a rilascio modificato contenente bupropionehc1 come sostanza attiva
ATE296606T1 (de) Schnell freisetzende farmazeutische darreichungsform enthaltend polymorphes tibolon
DE10081277D2 (de) Kapsel mit kontrollierter Wirkstofffreisetzung
ITMI20000972A0 (it) Formulazioni farmaceutiche, a rilascio modificato, con elevata biodisponibilita', contenenti principi attivi ad attivita' antibiotica.
DK0984774T3 (da) Mikrosfærer med gastroretentivt reguleret frigivelse til forbedret lægemiddelafgivelse
AU2002229434A1 (en) Controlled release microsphere system for administration of drug to the eye
AU2002350829A1 (en) Pharmaceutical composition for releasing an active substance at the colon